Aptus Pharma Limited engages in the marketing and distribution of finished pharmaceutical formulations. The company operates through four divisions: Aptus Pharma, Pioneer division which includes marketing of acute therapies including general anti-infectives, pain management, antacids, and gastrointestinal drugs; Aptus CD Care, Cardiac Diabetic division which includes marketing of chronic therapies, including anti-hypertensive, anti-diabetic, and lipid-lowering; Aptus Wellcare offers wellness and nutraceutical products, over-the-counter (OTC) formulations, and personal care products; and Aptus Global, export division engages in exploring and developing opportunities in overseas markets, semi-regulated and emerging countries. It also offers anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, antidiabetic, lipid-lowering, and general wellness products. Its products are available in balms,
| Current Price | ₹229.25 |
|---|---|
| Market Cap | ₹393 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Distributors > Health Care; Health Care Equipment and Services; Health Care Providers and Services; Health Care Distributors; Pharmaceutical Product Distribution |
| P/E Ratio | 73.7 |
| Beta (1Y) | -0.47 |
1. Pharmaceuticals, Medicinal Chemicals, and Botanical Products-100%
Aptus Pharma Limited is trading at ₹229.25, with a market capitalisation of ₹393 Cr.
Aptus Pharma Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors > Health Care; Health Care Equipment and Services; Health Care Providers and Services; Health Care Distributors; Pharmaceutical Product Distribution).
Aptus Pharma Limited has a P/E of 73.7.